tradingkey.logo
搜索

Catheter Precision Inc

VTAK
添加自选
0.252USD
-0.026-9.36%
收盘 07-31 16:00美东报价延迟15分钟
677.70K总市值
亏损市盈率 TTM

关于 Catheter Precision Inc 公司

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

Catheter Precision Inc简介

公司代码VTAK
公司名称Catheter Precision Inc
上市日期Sep 27, 2018
CEOJenkins (David A)
员工数量22
证券类型Ordinary Share
年结日Sep 27
公司地址1670 Highway 160 West
城市FORT MILL
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编29708
电话19736912000
网址https://www.ramed.com/
公司代码VTAK
上市日期Sep 27, 2018
CEOJenkins (David A)

Catheter Precision Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
48.49K
+54.05%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
48.49K
+54.05%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--

常见问题

Catheter Precision Inc的前五大股东是谁?

Catheter Precision Inc 的前五大股东如下:Mr. David Jenkins

有多少机构持有Catheter Precision Inc(VTAK)的股份?

截至2026Q1,共有28家机构持有Catheter Precision Inc的股份,合计持有的股份价值约为304.48K,占公司总股份的11.31%。与2025Q4相比,机构持股有所增加,增幅为230261.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有